On March 25, 2019, Legacy Pharmaceutical Packaging issued a voluntary recall of 40 lots of Losartan potassium tablets due to NMBA. Legacy Pharmaceuticals also expanded its recall to include 1 additional lot of Losartan. If you experience negative side effects while taking this drug, a number of other medications are available that work differently than Losartan. Now … Tests found trace amounts of … The recall affects Losartan Potassium Film-coated tablets, both 50mg and 100mg, which come in packs of 28. The recall involves both losartan potassium/hydrochlorothiazide tablets and losartan potassium tablets. A maker of losartan potassium is recalling this medicine because they may have small amounts of an ingredient which could cause cancer. 2019-01-04 12:27:00. Kristen Coppock, MA, Editor Torrent Pharmaceuticals has announced a new expansion of its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP to the consumer level. We wanted to let you know that certain manufacturers have issued a recall of select lots of Losartan Potassium 100mg Tablets. The FDA investigation is still ongoing. Losartan affected by the recall are 100 milligram/25 milligram tablets with the lot number JB8912. Losartan potassium and hydrochlorothiazide 50 mg/12.5 mg contains 4.24 mg (0.108 mEq) of potassium, losartan potassium and hydrochlorothiazide 100 mg/12.5 mg contains 8.48 mg (0.217 mEq) of potassium, and losartan potassium and hydrochlorothiazide 100 mg/25 mg contains 8.48 mg (0.217 mEq) of potassium. This time, the recall affects 5 lots: 3 lots of losartan potassium tablets and 2 lots of losartan/hydrochlorothiazide tablets. Losartan Lawsuits The recall is expanded to include an additional 3 lots of Losartan Potassium Tablets USP and 2 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help. On April 18, the FDA issued a voluntary national recall of Losartan Potassium tablets, USP and Losartan Potassium/Hydrochlorothiazide tablets, USP. Class 2 Medicines recall: Accord Healthcare Limited - Losartan Potassium 50mg Film-coated Tablets, PL 20075/0022 and Losartan Potassium 100mg Film-coated Tablets, PL 20075/0023 Description: This recall involves bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain lot numbers. A recall of Torrent Pharmaceuticals Limited ’ s Losartan Potassium Tablets USP has been expanded to include 8 additional lots. The company initiated another voluntary recall on June 25, 2019 of 32 lots of losartan potassium USP tablets and losartan potassium/hydrochlorothiazide combination … Originally the company recalled 10 lots of the medication. To date, no harmful side effects have been reported due to this recall. The contaminated medication was not distributed before Oct. 8. Here’s some information from the FDA about the Losartan recall: Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in … The recall is due trace amounts of an unexpected impurity, N-Methylnitrosobutyric acid (NMBA), detected during testing. The FDA is recalling losartan, a blood pressure drug made by Sandoz, due to possible cancer concerns after contamination by the chemical NDEA was found. Now, almost a year later, manufacturer Torrent Pharmaceuticals expands its voluntary recall for the 5th time. Teva Pharmaceuticals announced a recall for Losartan that was sold by Golden State Medical Supply. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. Losartan is a type of blood pressure medication that works by blocking receptors for angiotensin, an enzyme that can cause blood pressure to increase. The recalled bottles have “Sandoz,” the name of the medication, dosage, and NDC on the front of the bottle labels and the lot number and expiration date on the side of the bottle labels. In November, the FDA announced a voluntary recall of losartan potassium/hydrochlorothiazide, 100 mg/25 mg tablets in 1,000-count plastic bottles, NDC 0781-5207-10, Lot number JB8912, Exp. March 4, 2019 Less than a week after Camber Pharmaceuticals issued its nationwide recall for Losartan tablets, Torrent Pharmaceuticals has issued its own recall for 60 lots of Losartan potassium tablets USP and 54 lots of Losartan potassium/ hydrochlor… Losartan potassium tablets sold by Macleods Pharmaceuticals were recalled after trace amounts of a probable carcinogen known as NMBA were found in … This is part of an ongoi n g issue with angiotensin II receptor blocker (ARB) medications. The Sandoz Inc. recall involved 100 milligram/25 milligram Losartan tablets with the lot number JB8912 and expiration date of June 2020. The FDA is alerting patients and health care professionals to a voluntary recall of 44 lots of losartan potassium tablets by Teva Pharmaceuticals USA and … The lots include losartan potassium tablets and losartan potassium/hydrochlorothiazide tablets. Losartan may also be used for purposes not listed in this medication guide. This is the fifth time in 2019 that Torrent Pharmaceuticals has expanded its voluntary recall … Torrent Pharmaceuticals Limited has expanded its recall of Losartan potassium tablets USP. For the latest recall information as of September 25, 2019 check here: New Recall Expansion Announced for Certain Losartan Products. In addition to treating high blood pressure, losartan is prescribed to protect the kidneys from damage that can occur in people with type 2 diabetes. Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity while testing the below finished product batches manufactured utilizing active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited … Losartan works by allowing the blood vessels to open and be more relaxed. Losartan is used to slow long-term kidney damage in people with type 2 diabetes who also have high blood pressure. Losartan and losartan potassium are the same medication and belong to a class of drugs called angiotensin II receptor blockers (ARBs). A total of 10 lots are now being recalled at the consumer level, including 2 recalled lots initially announced December 20, … It is also used to lower the risk of stroke in certain people with heart disease. April 2019 — Torrent Pharmaceuticals Ltd. announced a voluntary recall for Losartan Potassium Tablets USP and Losartan Potassium/Hydrochlorothiazide tablets. Another Losartan Potassium recall has been issued following two other recalls for blood pressure medication made over the last few weeks. Losartan potassium is a drug used to treat high blood pressure and heart failure. The expiry dates of the packets are in June 2019, November 2019 and August 2020. 1 Teva Pharmaceuticals USA is recalling Losartan Potassium tablets, a prescription drug used to treat high blood pressure and congestive heart failure. The affected lots are being recalled due to an unexpected impurity in the manufacturers’ active pharmaceutical ingredient (API). Free Confidential Lawsuit Evaluation: If you or a loved one has been diagnosed with cancer after taking Losartan, you should contact our law firm immediately. Losartan is used to treat high blood pressure (hypertension). Last month, Torrent Pharmaceuticals Limited issued a voluntary recall of two lots of Losartan potassium tablets over similar concerns surrounding trace amounts of … Losartan is considered a generic angiotensin II receptor blocker (ARB), and is primarily … FDA alerts patients and health care professionals to Sandoz’s losartan potassium and hydrochlorothiazide recall of one lot due to NDEA. We understand that this medicine is important to your health.
losartan potassium recall 2021